Genetic background is an important determinant of metastatic potential.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

46 citing papers in PubMed.

1. Investigating the role of UBASH3B in cancer: structural relevance, physiological functions, and therapeutic possibilities.Journal of experimental & clinical cancer research : CR · 2025
   Review
2. Impact ofCancers · 2024
   Article
3. High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients.BMC cancer · 2023
   Article
4. Role of germline variants in the metastasis of breast carcinomas.Oncotarget · 2022
   Article
5. Genetic relationship analysis and molecular fingerprint identification of the tea germplasms from Guangxi Province, China.Breeding science · 2021
   Article
6. Molecular principles of metastasis: a hallmark of cancer revisited.Signal transduction and targeted therapy · 2020
   Review
7. A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer.Breast cancer : basic and clinical research · 2020
   Review
8. Cancer stem cells as key drivers of tumour progression.Journal of biomedical science · 2018
   Review
9. Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma.PloS one · 2016
   Article
10. MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transition.OncoTargets and therapy · 2016
    Article
11. [Regulation Mechanism of MTA3 in the Apoptosis of NSCLC Cells].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2015
    Article
12. The role of individual inheritance in tumor progression and metastasis.Journal of molecular medicine (Berlin, Germany) · 2015
    Review
13. Abnormal expression of FLOT1 correlates with tumor progression and poor survival in patients with non-small cell lung cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
14. Pttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
15. Overexpression of MTA3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer.PloS one · 2013
    Article
16. Seed, soil, and beyond: The basic biology of brain metastasis.Surgical neurology international · 2013
    Article
17. Animal models and conserved processes.Theoretical biology & medical modelling · 2012
    Article
18. A methodological approach to unravel organ-specific breast cancer metastasis.Journal of mammary gland biology and neoplasia · 2012
    Review
19. Behavior of seeds and soil in the mechanism of metastasis: a deeper understanding.Cancer science · 2012
    Review
20. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.Breast cancer research : BCR · 2012
    Article

Corrections and comments

• Comment on
  A molecular signature of metastasis in primary solid tumors.2003

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as